U.S. flag

An official website of the United States government

NM_005477.3(HCN4):c.2878CCACCC[1] (p.Pro962_Pro963del) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 19, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002484369.1

Allele description [Variation Report for NM_005477.3(HCN4):c.2878CCACCC[1] (p.Pro962_Pro963del)]

NM_005477.3(HCN4):c.2878CCACCC[1] (p.Pro962_Pro963del)

Gene:
HCN4:hyperpolarization activated cyclic nucleotide gated potassium channel 4 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
15q24.1
Genomic location:
Preferred name:
NM_005477.3(HCN4):c.2878CCACCC[1] (p.Pro962_Pro963del)
HGVS:
  • NC_000015.10:g.73323204GGGTGG[1]
  • NG_009063.1:g.51050CCACCC[1]
  • NM_005477.3:c.2878CCACCC[1]MANE SELECT
  • NP_005468.1:p.Pro962_Pro963del
  • NC_000015.9:g.73615545GGGTGG[1]
  • NC_000015.9:g.73615545_73615550del
  • NM_005477.2:c.2884_2889del
  • NM_005477.3:c.2884_2889delMANE SELECT
Links:
dbSNP: rs750207209
NCBI 1000 Genomes Browser:
rs750207209
Molecular consequence:
  • NM_005477.3:c.2878CCACCC[1] - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Sick sinus syndrome 2, autosomal dominant (SSS2)
Synonyms:
ATRIAL FIBRILLATION WITH BRADYARRHYTHMIA; SINUS BRADYCARDIA SYNDROME, FAMILIAL, AUTOSOMAL DOMINANT; SINUS NODE DISEASE, FAMILIAL, AUTOSOMAL DOMINANT; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008102; MedGen: C1834144; Orphanet: 166282; OMIM: 163800
Name:
Brugada syndrome 8 (BRGDA8)
Identifiers:
MONDO: MONDO:0013148; MedGen: C2751083; Orphanet: 130; OMIM: 613123
Name:
Epilepsy, idiopathic generalized, susceptibility to, 18
Identifiers:
MONDO: MONDO:0030434; MedGen: C5561983; OMIM: 619521

Recent activity

Clear Turn Off Turn On
  • Estrogen Antagonists
    Estrogen Antagonists
    Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.<br/>Year introduced: 1978
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002793438Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)		Uncertain significance
(Oct 19, 2021) 		unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002793438.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024